| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.006 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.009 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |